Reduce Risk of Opioid Overdose Deaths by Avoiding and Reducing Co-Prescribing Benzodiazepines


This MLN Matters article describes the latest key issues related to co-prescribing benzodiazepines (BZDs) with opioids. It summarizes multiple strategies to reduce the impact of this potentially dangerous practice, with a focus on patient health, safety, and well-being.




Last Updated: 07/11/2019